Cart
sales@molnova.com
Melagatran
CAS No. 159776-70-2
Melagatran( —— )
Catalog No. M33015 CAS No. 159776-70-2
Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 1131 | In Stock |
|
| 5MG | 1197 | In Stock |
|
| 10MG | 1549 | In Stock |
|
| 25MG | 2337 | In Stock |
|
| 50MG | 3060 | In Stock |
|
| 100MG | 4157 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMelagatran
-
NoteResearch use only, not for human use.
-
Brief DescriptionMelagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.
-
DescriptionMelagatran is a direct and orally active inhibitor of thrombin, without interacting with any other enzymes in the coagulation cascade or fibrinolytic enzymes aside from thrombin. Melagatran does not require endogenous co-factors for its antithrombin effect and may help to alleviate some of the damaging effects of endotoxemia. Melagatran has the potential to provide a rational approach in the prevention of arterial occlusion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number159776-70-2
-
Formula Weight429.51
-
Molecular FormulaC22H31N5O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](NCC(O)=O)C1CCCCC1)(=O)N2[C@H](C(NCC3=CC=C(C(=N)N)C=C3)=O)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eriksson M, et al. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Expert Opin Investig Drugs. 2000 May;9(5):1129-37.?
molnova catalog
related products
-
Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).
-
Eltrombopag
Eltrombopag is an orally active thrombopoietin receptor agonist with megakaryopoiesis stimulating activity.
-
Dabigatran ethyl est...
A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
